AuditLine › HHS OIG › Food and Drug Administration
HHS OIG recommendation 18-E-09-036.01
FDA should promote the use of presubmission meetings to address cybersecurity-related questions.
The recommendation, in the publisher's words
FDA should promote the use of presubmission meetings to address cybersecurity-related questions.
- Responsible agency
- Food and Drug Administration
- Issued
- September 10, 2018
- Report
- FDA Should Further Integrate Its Review of Cybersecurity Into the Premarket Review Process for Medical Devices (OEI-09-16-00220) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Concur (as recorded by the publisher)
- Closed
- February 21, 2020 (publisher's date)
- Publisher topics
- Food; Drug and Device Safety, Information Technology and Cybersecurity, Medical Supplies and Equipment
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
2 more, of which 0 are open in the publisher's file.
- FDA should include cybersecurity documentation as a criterion in FDA�s Refuse-to-Accept checklists.HHS OIG 18-E-09-036.02 · issued Sep 10, 2018 · closed Feb 21, 2020Closed Implemented
- FDA should include cybersecurity as an element in the Smart template.HHS OIG 18-E-09-036.03 · issued Sep 10, 2018 · closed Feb 21, 2020Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.